The store will not work correctly when cookies are disabled.
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis.
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.